December 21, 2009 โ€“ The recently introduced GORE PROPATEN Vascular Graft has integrated rings that reduce the cross-sectional profile by 24 percent as compared to externally ringed grafts, and its radial reinforcement allows for improved blood flow.

December 18, 2009 โ€“ Results from the Europella registry, evaluating the safety and feasibility of the Abiomed Impella 2.5 circulatory assist device in high-risk percutaneous coronary intervention (PCI) procedures, was published in the Dec. 15 issue of the Journal of the American College of Cardiology (JACC).

December 18, 2009 - The U.S. radiopharmacy network currently owned by Covidien is being sold to Triad Isotopes in a deal announced today.

Covidien said it decided to divest its network of 37 Mallinckrodt radiopharmacies after evaluating the radiotracer market. The company said it wants to streamline its portfolio and concentrate resources in its faster-growing, higher-margin businesses.

December 19, 2009 โ€“ A new, non-electronic computed tomography (CT) radiation dosimeter was released this week. The RADView CT dosimeter is manufactured in the form of a badge, smaller than a credit card, and contains radiation-sensitive film.

December 17, 2009 โ€“ The American College of Cardiology (ACC) recently certified LUMEDX, a provider of integrated cardiovascular imaging and information systems, as an ACC-NCDR ACTION Registry-GWTG software vendor.

December 17, 2009 โ€“ The University of Virginia (UVa) in Charlottesville and AstraZeneca this week entered into a strategic research collaboration to enhance development of new treatments, primarily for coronary artery disease (CAD) with a secondary focus on peripheral vascular disease (PAD).

December 16, 2009 - Many healthcare providers who are pursuing meaningful use objectives and meeting with deadlines defined within the HITECH provision of the American Recovery and Reinvestment Act (ARRA) are challenged with securing the capital investment needed to meet the aggressive schedules.

December 16, 2009 - Non-enhanced CT for calcium detection is a reliable way to exclude obstructive coronary artery disease in patients with chest pain, according to a study published in the December issue of the American Journal of Cardiology.

December 16, 2009 โ€“ The FDA's Endocrinologic and Metabolic Drugs Advisory Committee yesterday agreed AstraZeneca established sufficient benefit with trial data showing prophylactic benefit of prescribing CRESTOR (rosuvastatin calcium) to healthy individuals to prevent heart disease.

December 16, 2009 โ€“ Patient enrollment was recently completed for a study evaluating the ability of cardiopoietic cells to restore cardiac function in heart failure patients.

Subscribe to
ยฉ Copyright Wainscot Media. All Rights Reserved.
Subscribe Now